X
    X
    X
    X

    What’s Next for CBD? FDA Speaks

    Speaking Engagement

    Ryan Holz, Doug Sargent and David Standa presented at the Celesq AttorneysEdCenter Webinar, What’s Next for CBD? FDA Speaks, on June 10, 2019. 

    Fresh off the Food and Drug Administration’s May 31, 2019 public hearing regarding CBD and CBD-infused foods and beverages, this webcast analyzed the current state of affairs of the CBD industry. The webcast focused on what is happening on the legislative and regulatory side by recapping the May 31 hearing, analyzing the FDA’s recent warnings to companies touting health benefits related to CBD products, and evaluating what to expect going forward with respect to the FDA’s regulation of CBD. The webcast focused on the business side, analyzing recent decisions from major retailers and fast food companies to sell and market CBD products and how those decisions are likely to impact the policymakers in Washington.

    For more information, please click here.


    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.